These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 24490508)
1. [The value of different obese criteria for the assessment of insulin resistance in women with polycystic ovary syndrome]. Chen L; Lan Z; Zhang D Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):945-9. PubMed ID: 24490508 [TBL] [Abstract][Full Text] [Related]
2. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
4. Glucose intolerance in Japanese patients with polycystic ovary syndrome. Kurioka H; Takahashi K; Miyazaki K Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071 [TBL] [Abstract][Full Text] [Related]
5. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients. Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989 [TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome. Velija-Ašimi Z Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360 [TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. Durmus U; Duran C; Ecirli S J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846 [TBL] [Abstract][Full Text] [Related]
10. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Chen L; Xu WM; Zhang D Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406 [TBL] [Abstract][Full Text] [Related]
11. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. Gateva AT; Kamenov ZA Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):161-6. PubMed ID: 22727921 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189 [TBL] [Abstract][Full Text] [Related]
13. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF; Li X; Zhu MW Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552 [TBL] [Abstract][Full Text] [Related]
15. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China. Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and overweight-obese women with polycystic ovary syndrome. Bhattacharya SM Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118 [TBL] [Abstract][Full Text] [Related]
17. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk. Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436 [TBL] [Abstract][Full Text] [Related]
18. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743 [TBL] [Abstract][Full Text] [Related]
19. [Acupuncture Treatment of Polycystic Ovarian Syndrome Patients with Abdominal Obesity by Regulating Dai Meridian: A Randomized Controlled Clinical Trial]. Shen LY; Liang CM; Yang WJ; Pan L; Li H; Hu H Zhen Ci Yan Jiu; 2018 Apr; 43(4):255-9. PubMed ID: 29888581 [TBL] [Abstract][Full Text] [Related]
20. Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome. Oh JY; Sung YA; Lee HJ; Oh JY; Chung HW; Park H Obesity (Silver Spring); 2010 Mar; 18(3):593-7. PubMed ID: 19763092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]